{"id":199916,"date":"2026-05-28T11:10:03","date_gmt":"2026-05-28T15:10:03","guid":{"rendered":"https:\/\/midatlanticconsulting.com\/blog\/?p=199916"},"modified":"2026-05-28T11:10:03","modified_gmt":"2026-05-28T15:10:03","slug":"apple-shifts-leadership-on-long-running-non-invasive-blood-glucose-monitoring-project-for-apple-watch-signaling-potential-progress","status":"publish","type":"post","link":"https:\/\/midatlanticconsulting.com\/blog\/2026\/05\/apple-shifts-leadership-on-long-running-non-invasive-blood-glucose-monitoring-project-for-apple-watch-signaling-potential-progress\/","title":{"rendered":"Apple shifts leadership on long-running non-invasive blood glucose monitoring project for Apple Watch, signaling potential progress"},"content":{"rendered":"\n<p><a href=\"https:\/\/i0.wp.com\/macdailynews.com\/wp-content\/uploads\/2020\/09\/200915_apple_watch_series_6_04.png?ssl=1\"><img loading=\"lazy\" decoding=\"async\" data-recalc-dims=\"1\" src=\"https:\/\/i0.wp.com\/macdailynews.com\/wp-content\/uploads\/2020\/09\/200915_apple_watch_series_6_04.png?resize=640%2C562ssl=1\" alt=\"\" width=\"640\" height=\"562\" class=\"alignnone size-full wp-image-238114\" \/><\/a><\/p>\n<p>Apple has been working on non-invasive blood glucose monitoring for the Apple Watch for more than 15 years, a potential game-changing feature that could transform diabetes management by eliminating the need for finger pricks or separate continuous glucose monitors. According to <em>Bloomberg News<\/em>\u2018 Mark Gurman, the project has recently seen a significant leadership change that some interpret as a positive development.<\/p>\n<p>Gurman reports that Apple shifted oversight of the blood sugar monitoring initiative from platform architecture chief Tim Millet to Zongjian Chen, a senior engineer known for delivering results on advanced technologies.<\/p>\n<p>Gurman wrote: \u201cSome view the transition as a sign the work may finally be progressing to a point where Chen, known as someone who delivers, can ramp up development of the technology into an eventual consumer-grade offering.\u201d<\/p>\n<p>This move comes amid ongoing efforts to bring the ambitious health feature to market. In 2023, Gurman detailed how Apple\u2019s system is expected to function using optical technology rather than invasive sensors.<\/p>\n<p>As Gurman previously explained: \u201cThe system uses lasers to emit specific wavelengths of light into an area below the skin where there is interstitial fluid \u2014 substances that leak out of capillaries \u2014 that can be absorbed by glucose. The light is then reflected back to the sensor in a way that indicates the concentration of glucose.\u201d<\/p>\n<p>An algorithm would then process the data to determine blood glucose levels, with the potential to alert users to signs of prediabetes in addition to helping those already diagnosed with diabetes.<\/p>\n<p>While the leadership shift has generated optimism among those following the project, Gurman and analysts caution that a consumer-ready version remains years away \u2014 if it arrives at all. Technical challenges around accuracy, regulatory approval, and reliability for medical use are substantial. Still, successfully integrating non-invasive blood sugar monitoring would make the Apple Watch an indispensable tool for millions, offering unprecedented convenience and comfort in daily health tracking.<\/p>\n<p>The development underscores Apple\u2019s continued heavy investment in health features, building on existing capabilities like ECG, blood oxygen sensing, and irregular heart rhythm notifications. For people living with diabetes or at risk of prediabetes, this remains one of the most anticipated advancements in wearable technology. Stay tuned for further updates as the project evolves under its new leadership.<\/p>\n<p>If non-invasive blood glucose monitoring comes to Apple Watch, the company will not be able to make enough of them to satisfy demand.<\/p>\n<hr \/>\n<p>\u200e <\/p>\n<p><\/a>.<\/p>\n<div id=\"macdailynews-4019645517\" class=\"macdailynews-after-content macdailynews-entity-placement macdailynews-target macdailynews-target\" data-macdailynews-trackid=\"221186\" data-macdailynews-trackbid=\"1\"><ins class=\"adsbygoogle\" style=\"display:block\" data-ad-client=\"ca-pub-9654279268749293\" data-ad-slot=\"3250525581\" data-ad-format=\"auto\" data-full-width-responsive=\"false\"><\/ins>  <\/div>\n<p>Source link: https:\/\/macdailynews.com\/2026\/05\/26\/apple-shifts-leadership-on-long-running-non-invasive-blood-glucose-monitoring-project-for-apple-watch-signaling-potential-progress\/<\/p>\n <!-- Easy AdSense Pro: WP is not in the loop.  -->\n","protected":false},"excerpt":{"rendered":"<p>Apple has been working on non-invasive blood glucose monitoring for the Apple Watch for more than 15 years, a potential game-changing feature that could transform diabetes management by eliminating the need for finger pricks or separate continuous glucose monitors. According to Bloomberg News\u2018 Mark Gurman, the project has recently seen a significant leadership change that [&hellip;]<\/p>\n","protected":false},"author":29,"featured_media":77917,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,12],"tags":[],"class_list":["post-199916","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allnews","category-appleindustrynews"],"_links":{"self":[{"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/posts\/199916","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/comments?post=199916"}],"version-history":[{"count":1,"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/posts\/199916\/revisions"}],"predecessor-version":[{"id":199917,"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/posts\/199916\/revisions\/199917"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/media\/77917"}],"wp:attachment":[{"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/media?parent=199916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/categories?post=199916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/midatlanticconsulting.com\/blog\/wp-json\/wp\/v2\/tags?post=199916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}